B.C. startup Eupraxia attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange [Toronto Globe and Mail (Ontario, Canada)]
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.xenon-pharma.com
Company Research
Source: Toronto Globe and Mail
B.C. startup Eupraxia attempting rare TSX-only biotech IPO, raising hopes for revival of issues on senior Canadian exchange B.C.’s Eupraxia Pharmaceuticals Inc. is trying to accomplish something no other Canadian biotech startup has done in 18 years: go public solely on the Toronto Stock Exchange. The proposed $50-million IPO, underwritten by Raymond James, BMO Nesbitt Burns and Canaccord Genuity, is being closely watched by Canada’s life sciences sector. “If it’s successful … it could pave the way for other high quality, innovative Canadian biotech and therapeutics companies to use a Canadian IPO as a springboard for scaling their businesses,” said Peter van der Velden, managing general partner with Toronto-based biotech financier Lumira Ventures. Victoria-based Eupraxia was hoping to price the deal on Wednesday after setting an initial range of $9 to $11 a share. After a bad day for biotech stocks on Tuesday, however, a few expected institutional orders didn’t come through, promptin
Show less
Read more
Impact Snapshot
Event Time:
XENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XENE alerts
High impacting Xenon Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
XENE
News
- Xenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]Yahoo! Finance
- Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS DaysGlobeNewswire
- Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ... [Yahoo! Finance]Yahoo! Finance
- Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024GlobeNewswire
- Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
XENE
Earnings
- 2/29/24 - Beat
XENE
Sec Filings
- 3/12/24 - Form 4
- 3/12/24 - Form 4
- 3/12/24 - Form 4
- XENE's page on the SEC website